BlueCrest Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

BlueCrest Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,530	Closed	-$447K	–	1277
2019 Q1	$447K	Buy	23,530 +8,390	+55%	+$136K	0.02%	527
2018 Q4	$204K	Buy	+15,140	New	+$169K	0.01%	646

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

BlueCrest Capital Management's OSIR Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 23,530 shares — an estimated $447K sold.

BlueCrest Capital Management first reported a position in OSIR in Q4 2018 and held it in 2 quarters. The position peaked at $447K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

BlueCrest Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 23,530 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $447K.
BlueCrest Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
BlueCrest Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $447K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.